Navigation Links
American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide
Date:9/5/2012

t of hypertension to lower blood pressure in adults and may be used in patients not adequately controlled with monotherapy and as an initial therapy if a patient is likely to need multiple drugs to help achieve blood pressure goals. The recommended starting dose in adults is 40/12.5 mg taken orally once daily. The maximum recommended dose is 40/25 mg.

Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and heart attacks. There are no controlled trials demonstrating risk reduction with Edarbyclor, but trials with chlorthalidone and at least one pharmacologically similar drug to azilsartan medoxomil have demonstrated such benefits. For example, ALLHAT and SHEP were landmark clinical trials that have shown that long-term use of chlorthalidone at doses of 12.5 mg to 25 mg was associated with reductions in risk of serious cardiovascular events, such as heart attack and stroke.

Important Safety Information
WARNING: FETAL TOXICITY See full Prescribing Information for complete boxed warning.
When pregnancy is detected, discontinue Edarbyclor as soon as possible.
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.

Edarbyclor is contraindicated in patients with anuria.

Fetal Toxicity: Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. When pregnancy is detected, discontinue Edarbyclor as soon as possible. Thiazides cross the placental barrier and appear in cord blood and may be associated with adverse reactions, including fetal or neonatal jaundice and thrombocytopenia.

In patients with an activated renin-angiotensin-aldosterone system (RAAS), such as volume- and/or salt-depleted patients, Edarbyclor can cause excessive hypotension. Correct volume or salt depletion prior to adminis
'/>"/>

SOURCE Takeda Pharmaceuticals U.S.A., Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. American Academy of Family Physicians Foundation Launches Cities for Life
2. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
3. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
4. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
5. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
6. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
7. NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
8. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
9. Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal System CIII Clinical Data At American Pain Society Annual Meeting
10. Percutaneous Tibial Nerve Stimulation Included in the American Urological Associations Overactive Bladder Clinical Treatment Guidelines
11. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Calif. , May 22, 2013 Rigel ... the clinical advancement of three programs in development. The ... a JAK/SYK inhibitor, R348, being developed by Rigel as ... programs are aimed at oncology targets and are being ... under development by BerGenBio AS (BerGenBio) and a ligase ...
(Date:5/22/2013)... , May 22, 2013 Assured Pharmacy, Inc. ... prescription medications to sufferers of chronic pain, announced it ... national investor relations firm, to raise its visibility and ... "Over the past year, we have proven our business ... announced plans to open two additional new pharmacies in ...
(Date:5/22/2013)... WomanCare Global recently launched Simplant in ... training initiative attended by 90 health care providers. ... http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) Simplant, a long-acting ... subdermal implant composed of two thin, flexible, silicone ... form of the hormone progestin). These are inserted ...
Breaking Medicine Technology:Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4Assured Pharmacy Hires Hayden IR 2Assured Pharmacy Hires Hayden IR 3WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile 2
... 7, 2011 Talyst announces AutoPharm® Mobile, an ... The mobile application can be conveniently accessed on ... efficiency and control across the health system. ... to have real-time access to medication inventory throughout ...
... NEW YORK, Dec. 7, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p098411/Global-Microscopes-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_I This report ... US$ Million by the following Product Segments: ...
Cached Medicine Technology:Talyst Releases AutoPharm Mobile 2Global Microscopes Industry 2
(Date:5/21/2013)... Springs, CO (PRWEB) May 22, 2013 ... plan for better nutrition--from farmers' markets filled with whole ... consumers make the most of the season the nutrition ... a healthier lifestyle not to miss. , 1. Eating ... weather that invites shoppers to linger and explore, spring ...
(Date:5/21/2013)... May 21, 2013 Standard advice for ... and little else. However given industry’s less than exceptional ... shoppers via the internet, Consumer Mattress Reports sets out ... Choosing The Best Mattress .” , This article addresses ... and suggestions that may not be readily apparent to ...
(Date:5/21/2013)... Atlanta, GA (PRWEB) May 21, 2013 Patients ... Dental Care who have lost teeth due to gum disease ... traditional surgery for gum disease treatment with laser gum ... implants, which have the highest success rate out of all ... Procedure (LANAP) is a relatively new procedure cleared by the ...
(Date:5/21/2013)... 21, 2013) Prostaglandin analogues (PGAs), drugs which lower ... for people with glaucoma, but their use is not ... vision, dryness, changes in eye color and other side ... drugs also cause upper and lower eyelid drooping and ... are described in PLOS ONE . , Researchers ...
(Date:5/21/2013)... HealthSmart continues to grow through strategic acquisitions and ... hiring of new talent in several areas, including Account ... Dawn Powell has joined the organization effective April 28, ... Management in the Central Region and is based in ... client management, employee benefits, and product development experience, she ...
Breaking Medicine News(10 mins):Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3Health News:Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article 2Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2Health News:Glaucoma drug can cause droopy eyelids 2Health News:New Talent Joins the HealthSmart Account Management Team 2
... of extensive surgery, researchers say , THURSDAY, Aug. 13 (HealthDay ... the extent of early breast cancer may do more harm ... said this use of MRI increases the likelihood that patients ... but that this more aggressive treatment doesn,t lead to improved ...
... , , , ... Inc. (NYSE Amex: KAD ), a leading provider of home care, ... for its fiscal first quarter ended June 30, 2009. , ... revenues of $26.4 million compared with $26.8 million for the same period last ...
... LOS ANGELES, Aug. 13 From cranky bosses to incompetent ... people encounter while making their way through the typical work day ... people up a wall. , , Tanna Marshall, ... 18 years, experience as a natural health practitioner, offers a collection ...
... ... the First in Georgia to Offer Online Records and Direct E-mail Access to Doctors, a ... ... affiliated with Northside Hospital, is leading the way as one of the first physicians’ offices ...
... NES ZIONA, Israel, August 13 Following the ... NanoPass,Technologies Ltd. (NanoPass) announced today that it has successfully,developed ... effectiveness and supply of pandemic flu vaccines. , ... 11th, 2009", said Dr Yotam Levin, the,Company,s CEO, "the ...
... , SEATTLE, Aug. 13 The ... been appointed to head its new European office in London, effective ... health policy and advocacy. , , "Expanding our ... we,re very pleased that Joe will be leading this effort," said ...
Cached Medicine News:Health News:Arcadia Resources Announces First Quarter Results 2Health News:Arcadia Resources Announces First Quarter Results 3Health News:Arcadia Resources Announces First Quarter Results 4Health News:Arcadia Resources Announces First Quarter Results 5Health News:Arcadia Resources Announces First Quarter Results 6Health News:Arcadia Resources Announces First Quarter Results 7Health News:Arcadia Resources Announces First Quarter Results 8Health News:Arcadia Resources Announces First Quarter Results 9Health News:Arcadia Resources Announces First Quarter Results 10Health News:Arcadia Resources Announces First Quarter Results 11Health News:Arcadia Resources Announces First Quarter Results 12Health News:Arcadia Resources Announces First Quarter Results 13Health News:Arcadia Resources Announces First Quarter Results 14Health News:Arcadia Resources Announces First Quarter Results 15Health News:'Living Peacefully in a Big City': Natural Health Practitioner Offers Advice on Maintaining Sanity, Health and Happiness 2Health News:'Living Peacefully in a Big City': Natural Health Practitioner Offers Advice on Maintaining Sanity, Health and Happiness 3Health News:Atlanta Women's Specialists Raises the Bar in Patient Care With Online Medical Records and an Electronic Medical Records System 2Health News:Atlanta Women's Specialists Raises the Bar in Patient Care With Online Medical Records and an Electronic Medical Records System 3Health News:Atlanta Women's Specialists Raises the Bar in Patient Care With Online Medical Records and an Electronic Medical Records System 4Health News:NanoPass Makes its MicronJet Technology Available to Increase Global Supply of Pandemic Influenza Vaccines 2Health News:NanoPass Makes its MicronJet Technology Available to Increase Global Supply of Pandemic Influenza Vaccines 3Health News:Bill & Melinda Gates Foundation Appoints Joe Cerrell to Lead New European Office 2Health News:Bill & Melinda Gates Foundation Appoints Joe Cerrell to Lead New European Office 3
... As part of our continued effort to standardize ... to introduce the new PowerPro® Electric II Handpiece ... single trigger handpiece, a dedicated oscillating saw, a ... to this system are features such as speed, ...
... power line from MicroAire. Our new ... electric instruments, offering the ultimate in ... has always wanted with the security ... Power Master oscillating saw, Available with ...
... Linvatec Advantage System is a full-function, ... electric handpieces for a wide range ... Bone Orthopedics, Small Bone Orthopedics, Orthopedic ... Neurosurgery, and Spine Surgery. Because it ...
... System consists of a pistol-grip handpiece available ... a wide range of couplers that can ... surgical applications., ,MicroAire SmartDriver. Modular Pistol-Grip ... with different module for drilling, pinning, cutting, ...
Medicine Products: